Evidence map›Paper›PMID 33988309›Full record

ArticleActa ophthalmologica2022

Feasibility and tolerability of ophthalmic virtual reality as a medical communication tool in children and young people.

Peter M Maloca, Emily A Williams, Faisal Mushtaq, Andreas Rueppel, Philipp L Müller, Clemens Lange, Emanuel R de Carvalho, Nadja Inglin, Michael Reich, Catherine Egan and 4 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta ophthalmologica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 4 countries.

Peter M MalocaInstitute of Molecular and Clinical Ophthalmology Basel, Basel, Switzerland.ORCID https://orcid.org/0000-0002-4794-5859
Emily A WilliamsSchool of Psychology, University of Leeds, Leeds, UK.
Faisal MushtaqSchool of Psychology, University of Leeds, Leeds, UK.
Andreas RueppelEye on Science, Zurich, Switzerland.
Philipp L MüllerMoorfields Eye Hospital NHS Foundation Trust, London, UK.
Clemens LangeEye Center, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Emanuel R de CarvalhoMoorfields Eye Hospital NHS Foundation Trust, London, UK.
Nadja InglinInstitute of Molecular and Clinical Ophthalmology Basel, Basel, Switzerland.
Michael ReichEye Center, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Catherine EganMoorfields Eye Hospital NHS Foundation Trust, London, UK.
Pascal W HaslerOCTlab, Department of Ophthalmology, University Hospital Basel, Basel, Switzerland.ORCID https://orcid.org/0000-0002-0356-8262
Adnan TufailMoorfields Eye Hospital NHS Foundation Trust, London, UK.
Hendrik P N SchollInstitute of Molecular and Clinical Ophthalmology Basel, Basel, Switzerland.
Philippe C CattinCenter for medical Image Analysis & Navigation, University, Basel, Switzerland.
Moorfields Eye Hospital NHS Foundation Trust · GBUniversity of Basel · CHUniversity of Freiburg · DEUniversity of Leeds · GBInstitute of Molecular and Clinical Ophthalmology Basel · CHLife Science Zurich · CH

Funding

Werner Siemens Foundation through the MIRACLE project.
6 · The paper itself

Abstract

purposeVirtual reality (VR) can be useful in explaining diseases and complications that affect children in order to improve medical communications with this vulnerable patient group. So far, children and young people's responses to high-end medical VR environments have never been assessed.

methodsAn unprecedented number of 320 children and young people were given the opportunity to interact with a VR application displaying original ophthalmic volume data via a commercially available tethered head-mounted display (HMD). Participants completed three surveys: demographics and experience with VR, usability and perceived utility of this technology and the Simulator Sickness Questionnaire. The second survey also probed participants for suggestions on improvements and whether this system could be useful for increasing engagement in science.

resultsA total of 206 sets of surveys were received. 165 children and young people (84 female) aged 12-18 years (mean, 15 years) completed surveys that could be used for analysis. 69 participants (47.59%) were VR-naïve, and 76 (52.41%) reported that they had previous VR experience. Results show that VR facilitated understanding of ophthalmological complications and was reasonably tolerated. Lastly, exposure to VR raised children and young people's awareness and interest in science.

conclusionsThe VR platform used was successfully utilized and was well accepted in children to display and interact with volume-rendered 3D ophthalmological data. Virtual reality (VR) is suitable as a novel image display platform in ophthalmology to engage children and young people.

Indexed as

Virtual RealityAdolescentChildFeasibility StudiesFemaleHumansMaleOphthalmologyPatient Education as TopicSurveys and Questionnaireschildrenoptical coherence tomographypoint-cloud dataray castingvirtual realityvolume rendering

Identifiers

PMID33988309
PMCPMC9290670
OpenAlexW3162169923

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.